These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 35111134)

  • 1. Independent Variables for Determining the Cumulative Live Birth Rates of Aged Patients with Polycystic Ovary Syndrome or Tubal Factor Infertility: A Retrospective Cohort Study.
    Guan Y; Kong P; Xiao Z; Zhang J; He J; Geng W; Yan J; Sun S; Mu M; Du X; Wang X
    Front Endocrinol (Lausanne); 2021; 12():728051. PubMed ID: 35111134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Cumulative Live Birth Rate Between Aged PCOS Women and Controls in IVF/ICSI Cycles.
    Mai Z; Liu M; Pan P; Li L; Huang J; Chen X; Yang D
    Front Endocrinol (Lausanne); 2021; 12():724333. PubMed ID: 34650517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Live birth rate per fresh embryo transfer and cumulative live birth rate in patients with PCOS under the POSEIDON classification: a retrospective study.
    Jiang L; Sun Y; Pan P; Li L; Yang D; Huang J; Li Y
    Front Endocrinol (Lausanne); 2024; 15():1348771. PubMed ID: 38863934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Serum Anti-Müllerian Hormone Concentrations Are Associated With Poor Pregnancy Outcome in Fresh IVF/ICSI Cycle but Not Cumulative Live Birth Rate in PCOS Patients.
    Guo Y; Liu S; Hu S; Li F; Jin L
    Front Endocrinol (Lausanne); 2021; 12():673284. PubMed ID: 34122349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.
    Toftager M; Bogstad J; Løssl K; Prætorius L; Zedeler A; Bryndorf T; Nilas L; Pinborg A
    Hum Reprod; 2017 Mar; 32(3):556-567. PubMed ID: 28130435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of IVF/ICSI outcome in patients with polycystic ovarian syndrome or tubal factor infertility.
    Okohue JE; Onuh SO; Ikimalo JI
    Niger J Clin Pract; 2013; 16(2):207-10. PubMed ID: 23563463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of IVF/ICSI outcomes in advanced reproductive age patients with polycystic ovary syndrome and advanced reproductive age normal controls: a retrospective cohort study.
    Zhang X; Lian F; Liu D
    BMC Pregnancy Childbirth; 2023 Jun; 23(1):440. PubMed ID: 37316805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cumulative live birth rates and number of oocytes retrieved in women of advanced age. A single centre analysis including 4500 women ≥38 years old.
    Devesa M; Tur R; Rodríguez I; Coroleu B; Martínez F; Polyzos NP
    Hum Reprod; 2018 Nov; 33(11):2010-2017. PubMed ID: 30272168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting cumulative live birth rate after the 1st oocyte retrieved in polycystic ovary syndrome patients in women during IVF/ICSI-ET.
    Li Y; Xia L; Li Z; Zhang Z; Jiang R
    J Ovarian Res; 2023 Oct; 16(1):201. PubMed ID: 37833722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the fertile window extended in women with polycystic ovary syndrome? Utilizing the Society for Assisted Reproductive Technology registry to assess the impact of reproductive aging on live-birth rate.
    Kalra SK; Ratcliffe SJ; Dokras A
    Fertil Steril; 2013 Jul; 100(1):208-13. PubMed ID: 23557762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The number of oocytes associated with maximum cumulative live birth rates per aspiration depends on female age: a population study of 221 221 treatment cycles.
    Law YJ; Zhang N; Venetis CA; Chambers GM; Harris K
    Hum Reprod; 2019 Sep; 34(9):1778-1787. PubMed ID: 31398253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of in-vitro oocyte maturation in patients with PCOS: does phenotype have an impact?
    Mackens S; Pareyn S; Drakopoulos P; Deckers T; Mostinckx L; Blockeel C; Segers I; Verheyen G; Santos-Ribeiro S; Tournaye H; De Vos M
    Hum Reprod; 2020 Oct; 35(10):2272-2279. PubMed ID: 32951028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cumulative live birth rates in low-prognosis women.
    Leijdekkers JA; Eijkemans MJC; van Tilborg TC; Oudshoorn SC; van Golde RJT; Hoek A; Lambalk CB; de Bruin JP; Fleischer K; Mochtar MH; Kuchenbecker WKH; Laven JSE; Mol BWJ; Torrance HL; Broekmans FJM;
    Hum Reprod; 2019 Jun; 34(6):1030-1041. PubMed ID: 31125412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cumulative live birth rates in more than 3,000 patients with poor ovarian response: a 15-year survey of final in vitro fertilization outcome.
    Xu B; Chen Y; Geerts D; Yue J; Li Z; Zhu G; Jin L
    Fertil Steril; 2018 Jun; 109(6):1051-1059. PubMed ID: 29935642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimüllerian hormone: prediction of cumulative live birth in gonadotropin-releasing hormone antagonist treatment for in vitro fertilization.
    Hamdine O; Eijkemans MJC; Lentjes EGW; Torrance HL; Macklon NS; Fauser BCJM; Broekmans FJ
    Fertil Steril; 2015 Oct; 104(4):891-898.e2. PubMed ID: 26196233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, clinical characteristics, and reproductive outcomes of polycystic ovary syndrome in older women referred for tertiary fertility care.
    Tannus S; Tan J; Son WY; Dahan MH
    Arch Gynecol Obstet; 2018 Apr; 297(4):1037-1042. PubMed ID: 29289990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cumulative live birth rates after IVF in patients with polycystic ovaries: phenotype matters.
    De Vos M; Pareyn S; Drakopoulos P; Raimundo JM; Anckaert E; Santos-Ribeiro S; Polyzos NP; Tournaye H; Blockeel C
    Reprod Biomed Online; 2018 Aug; 37(2):163-171. PubMed ID: 29778554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follicular fluid levels of anti-Mullerian hormone as a predictor of oocyte maturation, fertilization rate, and embryonic development in patients with polycystic ovary syndrome.
    Mashiach R; Amit A; Hasson J; Amzalzg S; Almog B; Ben-Yosef D; Lessing JB; Limor R; Azem F
    Fertil Steril; 2010 May; 93(7):2299-302. PubMed ID: 19261276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of polycystic ovarian syndrome on in vitro fertilization-embryo transfer outcomes are influenced by body mass index.
    McCormick B; Thomas M; Maxwell R; Williams D; Aubuchon M
    Fertil Steril; 2008 Dec; 90(6):2304-9. PubMed ID: 18191852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors for live birth after in vitro maturation of oocytes in women with polycystic ovary syndrome.
    Tannus S; Hatirnaz S; Tan J; Ata B; Tan SL; Hatirnaz E; Kenat-Pektas M; Dahan MH
    Arch Gynecol Obstet; 2018 Jan; 297(1):199-204. PubMed ID: 28993961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.